316 related articles for article (PubMed ID: 28622612)
41. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
42. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
43. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
[TBL] [Abstract][Full Text] [Related]
44. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
[TBL] [Abstract][Full Text] [Related]
45. Treatment of colorectal cancer in the elderly: a review of the literature.
Golfinopoulos V; Pentheroudakis G; Pavlidis N
Cancer Treat Rev; 2006 Feb; 32(1):1-8. PubMed ID: 16337087
[TBL] [Abstract][Full Text] [Related]
46. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
Booth CM; Nanji S; Wei X; Mackillop WJ
JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
[TBL] [Abstract][Full Text] [Related]
47. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.
Cercek A; Siegel CL; Capanu M; Reidy-Lagunes D; Saltz LB
Clin Colorectal Cancer; 2013 Sep; 12(3):163-7. PubMed ID: 23871161
[TBL] [Abstract][Full Text] [Related]
48. Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study.
Quipourt V; Jooste V; Cottet V; Faivre J; Bouvier AM
J Am Geriatr Soc; 2011 Apr; 59(4):694-8. PubMed ID: 21438864
[TBL] [Abstract][Full Text] [Related]
49. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
50. Impact of Dose Reductions, Delays Between Chemotherapy Cycles, and/or Shorter Courses of Adjuvant Chemotherapy in Stage II and III Colorectal Cancer Patients: a Single-Center Retrospective Study.
Sgouros J; Aravantinos G; Kouvatseas G; Rapti A; Stamoulis G; Bisvikis A; Res H; Samantas E
J Gastrointest Cancer; 2015 Dec; 46(4):343-9. PubMed ID: 26143067
[TBL] [Abstract][Full Text] [Related]
51. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients.
Jørgensen TL; Teiblum S; Paludan M; Poulsen LØ; Jørgensen AY; Bruun KH; Hallas J; Herrstedt J
Gynecol Oncol; 2012 Nov; 127(2):367-74. PubMed ID: 22800653
[TBL] [Abstract][Full Text] [Related]
52. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
[TBL] [Abstract][Full Text] [Related]
53. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
54. Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?
Soveri LM; Hermunen K; de Gramont A; Poussa T; Quinaux E; Bono P; André T; Österlund P
Eur J Cancer; 2014 Nov; 50(17):2966-74. PubMed ID: 25266443
[TBL] [Abstract][Full Text] [Related]
55. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
Aparicio T; Navazesh A; Boutron I; Bouarioua N; Chosidow D; Mion M; Choudat L; Sobhani I; Mentré F; Soulé JC
Crit Rev Oncol Hematol; 2009 Sep; 71(3):249-57. PubMed ID: 19131256
[TBL] [Abstract][Full Text] [Related]
56. Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer.
Hoshino N; Kawada K; Hida K; Goto S; Uozumi R; Hasegawa S; Sugihara K; Sakai Y
Med Oncol; 2017 Aug; 34(8):138. PubMed ID: 28699092
[TBL] [Abstract][Full Text] [Related]
57. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
58. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic clinical factors in colorectal cancer after radical therapy].
Novák P; Liska V; Treska V; Kopalová J; Vycítal O; Brůha J
Rozhl Chir; 2012 Apr; 91(4):219-29. PubMed ID: 22880270
[TBL] [Abstract][Full Text] [Related]
60. The impact of kidney function on colorectal cancer patients with localized and regional diseases: An observational study from Taiwan.
Chiang SF; Chen JS; Tang R; Yeh CY; Hsieh PS; Tsai WS; You JF; Hung HY; Lai CC; Lin JR; Chiang JM
Indian J Cancer; 2019; 56(3):241-247. PubMed ID: 31389388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
